The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
about
Microbiology laboratory and the management of mother-child varicella-zoster virus infectionHerpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspectiveSimilar herpes zoster incidence across Europe: results from a systematic literature reviewTime trends in pediatric hospitalizations for varicella infection are associated with climatic changes: a 22-year retrospective study in a tertiary Greek referral center.Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.Varicella vaccination in Europe - taking the practical approach.Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain).Incidence and effects of Varicella Zoster Virus infection on academic activities of medical undergraduates--a five-year follow-up study from Sri Lanka.Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain)The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands.Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.Systematic review of incidence and complications of herpes zoster: towards a global perspective.Hospitalization due to varicella in the NetherlandsThe burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey.Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands.Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care.Assessment of vaccine candidates for persons aged 50 and older: a review.Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Herpes zoster surveillance using electronic databases in the Valencian Community (Spain).Diffusion tensor magnetic resonance imaging of trigeminal nerves in relapsing herpetic keratouveitis.Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancerClinical manifestations of herpes zoster, its comorbidities, and its complications in north of iran from 2007 to 2013The clinical and epidemiological evolution of varicella in Romania during 2004 and 2013.Varicella immunity in Iran: an age-stratified systematic review and meta-analysis.Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.Herpes zoster-associated mortality in Europe: a systematic review.Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran.Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality.The burden of chickenpox disease in SwedenIncidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study.The epidemiology of Varicella Zoster Virus infection in ItalyThe epidemiological, clinical, and pathological rationale for the herpes zoster vaccine.Hospitalizations to treat herpes zoster in older adults: causes and validated rates.Postherpetic neuralgia in the elderly.Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.
P2860
Q26738745-B6D0B65E-3FF9-4DD7-896D-40BA2E67C374Q26781940-E31A4F39-0112-491C-B772-DDE878B05E33Q26824836-26EA0DE6-64E6-44DB-AB5E-4973E211EE5EQ30584282-6E644B16-6D1C-4231-9F31-47896541400BQ33386017-D1B036C0-38C7-46C2-A769-D84DDA5B3864Q33454919-02AF3686-AA7E-4A00-9CA6-8F2DD6E0609AQ33574978-09A05F1D-3E0A-428B-B808-1C5880C4FF4EQ33577488-640983A8-6DF4-4247-A758-18474E149B9BQ33578057-F9F22C9B-CEF9-48C1-AA1C-6E21B1235D72Q33611436-C695E9CC-C55F-451F-A87F-224C8BA766CDQ33657323-BE00DD93-D4D2-40EF-B445-B71F7B4CCD78Q33706387-50E714EB-EEE5-4EFB-9743-F279DF0B8E72Q33709036-2B148178-5CAF-4D45-BFFC-963E00544583Q33795551-B846F0C4-D3C6-4B66-BCD6-01322D290F01Q33863210-66895ADE-CB26-4777-88A0-8716DBFFB587Q34076833-418B9E1C-EBAD-4E08-9CC8-93FE4A643A72Q34101345-B734D623-5980-4D8E-8DE1-E788301DC704Q34265188-16EC5AD3-0B57-441F-B241-47F6262A47EDQ34313029-B237761C-3913-4CF5-865C-EE9357945021Q34314923-F79F3603-BB63-45E6-A5FF-C0AEC38BC470Q34668826-E8F19444-C309-4E00-B5A8-2F0D06FB1BD7Q34683751-53F45600-9674-4720-908F-1F71B0A42763Q35008196-D8681846-5499-4938-8B42-7C8836FDCD5FQ35242893-5455AA52-D9E0-41B0-AE6D-A1757DC33239Q35258843-ED94A69A-6404-4F76-B0EA-384F01B6A6DDQ35373216-23570835-8736-4FD8-A053-A50526EAF639Q35422661-753F0298-04F2-4522-8B42-4933417D6836Q35543651-120ACB56-35D6-4206-9708-0900346F1E49Q35607755-57C9B023-840C-4F70-BAA0-CF60C9881AE0Q35618741-4D95FF51-2ECE-42D0-9D92-30252436347FQ35627422-575767E1-DAAA-4F3F-AB90-79ADB88630C1Q35666726-9B08D05A-87C5-4D83-806D-9E8B9E086DA3Q35942170-68B3900E-6AE9-4E9C-B64C-084ED6C18D51Q36189093-7E185BA2-897C-4DD8-BA1D-0AA900500583Q36674803-5184D079-EBBF-4767-8BE5-F7E32C415094Q37011737-C97622CF-7601-4D3B-A62D-1DBD232EB742Q37141163-414F9BEF-3039-4D17-9B72-4CBF44128083Q37235263-2104E1E0-E141-466C-AB61-B0BBBC5021A3Q37427315-10232776-C94B-40E9-B5D3-1641964AFD67Q37538386-CA0CA237-F4DB-4B0F-8696-E777DCCEAEB0
P2860
The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The epidemiology of varicella ...... ella zoster virus vaccination.
@ast
The epidemiology of varicella ...... ella zoster virus vaccination.
@en
The epidemiology of varicella ...... ella zoster virus vaccination.
@nl
type
label
The epidemiology of varicella ...... ella zoster virus vaccination.
@ast
The epidemiology of varicella ...... ella zoster virus vaccination.
@en
The epidemiology of varicella ...... ella zoster virus vaccination.
@nl
prefLabel
The epidemiology of varicella ...... ella zoster virus vaccination.
@ast
The epidemiology of varicella ...... ella zoster virus vaccination.
@en
The epidemiology of varicella ...... ella zoster virus vaccination.
@nl
P2093
P1433
P1476
The epidemiology of varicella ...... cella zoster virus vaccination
@en
P2093
Guy Berbers
Hans Rümke
Hester de Melker
Susan Hahné
Susan van den Hof
P304
P356
10.1016/J.VACCINE.2006.02.017
P407
P577
2006-02-24T00:00:00Z